Your trusted resource for people with allergies, asthma, and related conditions
and for those who care for them
Allergy & Asthma Network unites and advocates on behalf of 60 million Americans with asthma, allergies, and related conditions.
Bulletin Board
February 10, 2026
Launching the Patient Advocacy Leadership Initiative (PALI)
PALI is a multifaceted program supporting a network of informed, empowered patient advocates to influence healthcare policy at federal, state and local levels. Advocates attend monthly virtual interactive meetings to learn how to get involved. PALI is an “investment in the power of a strong, connected advocacy community,” CEO Lynda Mitchell says.
Allergy & Asthma Network’s CEO Offers Perspective on Sublingual Epinephrine
Director of Advocacy Nissa Shaffi recently participated in a panel discussion hosted by the U.S. Food and Drug Administration (FDA) and the Duke-Margolis Institute for Health Policy on expanding access to epinephrine in community settings. Nissa detailed policy solutions to improve affordability, school staff training, and first responder resources while reducing insurance barriers so people can get life-saving care they need.
Allergy & Asthma Network’s Researchers Examine Macrolides in Asthma Care
Chief Research Officer De De Gardner and patient advocates Angel Melendez and Hilarry Orr were among co-authors of a new study on macrolide antibiotics in asthma care. Published in the Journal of Allergy and Clinical Immunology, the research found that macrolides reduced severe asthma attacks and improved quality of life, pointing to a promising new direction for asthma treatment.
Allergy & Asthma in the News
Podcasts
Meet the New President of the ACAAI
How Allergy & Asthma Network Supports Patients and Families
Measuring Asthma in Children Using the Peds-AIRQ
Recent & Upcoming Webinars
Check out our Events Calendar for Webinars, Trusted Messengers Events, and other Allergy & Asthma Network supported events.









